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Abstract: 
 
Aim: Using structural bioinformatics methods, the aim is to assess the hypothesis that hepatitis C 
virus (HCV) encodes a glutathione peroxidase (GPx) gene in an overlapping reading frame, 
linking HCV expression and pathogenesis to the Se status and dietary oxidant/antioxidant 
balance of the host. Methods: The putative HCV GPx gene was identified by searching viral 
sequence databases, using conserved GPx active site sequences as probes, giving particular 
weight to the UGA (selenocysteine) codon. Multiple sequence alignments were generated and 
analyzed to validate the sequence similarity, and to establish the degree of conservation of the 
identified genomic features in HCV. Molecular modeling was used to assess the structural 
feasibility of the proposed homology. Results: The GPx homology region overlaps the NS4 gene, 
and is well conserved in HCV. The sequence similarity of the conserved active site regions to a 
set of known GPx is high (4 to 6 SD greater than expected for similar random sequences). The 
computed strain energy of a molecular model of the HCV GPx is energetically favorable, 
comparable to the bovine GPx structure. Conclusions: By linking HCV replication and 
pathogenesis to the Se status and dietary oxidant/antioxidant balance of the host, the existence of 
a viral GPx gene could help to explain why HCV disease progression is accelerated by oxidant 
stresses such as alcoholism and iron overload. 
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Article: 
 
The possibility that viruses might encode selenoproteins remained unexplored until 1994 when 
Taylor et al. [10] published a study of the predicted RNA structure of the human 
immunodeficiency virus, HIV-1, in relation to potential novel open reading frames (ORFs, 
protein coding regions) of the virus. That analysis demonstrated the potential for several new 
gene variants in HIV-1, which might encode selenoproteins, because of the existence of several 
highly conserved UGA codons (which can encode selenocysteine) in certain regions of HIV. 
These UGA codons were consistently found to be downstream of potential RNA structural 
features ("slippery" sequences and RNA pseudoknots) that would be required for the expression 
of these hypothetical genes by ribosomal frameshifting. 
 
Subsequently, the hypothetical protein encoded by one of these predicted HIV-1 selenoprotein 
genes was shown to have highly significant sequence similarity to the active site domains of the 
mammalian selenoprotein glutathione peroxidase (GPx), despite being truncated by several 
internal and C-terminal deletions [8]. Along the same lines, highly truncated GPx-related 
sequences were identified in the potentially cardiovirulent Se-dependent B3 strain of 
coxsackievirus, CVB3 [9], which is the same strain that has been studied by Beck et at. [1] as a 
putative Keshan disease cofactor. 
 
The only experimentally verified example of a viral selenoprotein is from a DNA virus, the pox 
virus Molluscum contagiosum, which has been shown to encode a functional full length GPx 
enzyme [7]. Zhang et al. [11] subsequently reported that a number of RNA viruses encode GPx-
related sequences, including, in addition to the HIV-1 and CVB3 examples mentioned above, 
potential GPx genes in measles virus and the hepatitis C virus, HCV. Thus, it seems likely that 
this antioxidant selenoprotein module may prove to be a relatively common gene in both RNA 
and DNA viruses. 
 
The current paper focuses on the case of the hypothetical HCV GPx gene first predicted by 
Zhang et al. [11], which is of considerable interest because HCV infection is very prevalent 
worldwide, is considered an emerging public health threat, and has poorly understood 
mechanisms of pathogenesis. We will assess the hypothesis that the HCV encoded sequence is a 
GPx homologue by means of structural bioinformatics methods, including some preliminary 
results of homology molecular modeling studies of the HCV GPx protein structure, which will 
be reported in depth in a separate publication [3]. Finally, we will review clinical data and other 
lines of evidence that are consistent with this hypothesis, and consider its clinical implications. 
 
METHODS 
 
Database Searches and Potential Gene Identification 
 
As described previously by Zhang et al. [11], the potential HCV glutathione peroxidase (GPx) 
gene was identified by searching sequence databases with the program TFASTA, using known 
variants of several different GPx active site sequences as probes, e. g., VASYUGLT (plasma 
GPx), etc., where U represents the TGA codon in DNA, potentially encoding selenocysteine 
(Sec). An altered translation table was used, modified specifically so as to distinguish the TGA 
codon from the other 2 stop codons, as described in detail previously [11]. Highly ranked 
database hits were subsequently examined by translating all 3 reading frames in the region of the 
GPx sequence similarity, to determine the potential for expression of the potential gene by 
known mechanisms, i.e. a start codon, ribosomal frameshift site, or an RNA editing site. 
 
Sequence Alignment and Assessment of Statistical Significance of Sequence Similarities 
 
The BlockAlign program [11] was used to generate multiple sequence alignments; this program 
produces an optimal, gapped alignment of a probe sequence against an existing sequence 
alignment. Combined with a randomization routine, it was also used for assessing the statistical 
significance of the similarity between a query sequence and a prealigned protein family (in this 
case, a multiple alignment of GPx sequences). Briefly, the method involves 1. the optimal 
alignment of the query sequence against the prealigned family (GPx), which also yields a 
similarity score, followed by 2. repeated random shuttling and realignment of the query 
sequence, 3. calculation of the average similarity score and standard deviation for optimally 
aligned random sequences of identical composition to the query sequence. The significance of 
the query-family homology can then be expressed as a shuffling statistic (Z score), calculated as 
the distance of the actual score from the average random score, in standard deviations (SD). The 
blosum62 amino acid similarity matrix was used for all sequence alignments, and Sec residues 
were treated as Cys for the purpose of these calculations. 
 
Molecular Modeling 
 
The Sybyl program (Tripos Assoc., St. Louis, MO) was used to build a putative HCV viral GPx 
homology model, starting from the bovine cellular GPx X-ray crystal structure, file lGPl from 
the Brookhaven Protein Data Base. The model was constructed based on the alignment shown in 
simplified form in Figure 1 of Zhang et al. [11]. The model was constructed using the 
biopolymer protein-loop option of Sybyl, which uses a knowledge-based approach to rebuild 
regions where insertions and deletions are predicted by the alignment. 
 
The resulting model was refined by energy minimization using molecular mechanics; the final 
minimization used the Kollman all-atom force field as implemented in Sybyl. The Sec residue 
was modeled as the deprotonated Se-species. Default program options were used for the 
minimization, with a ΔE of 0.001 kcal/mol as the termination criterion in the final energy 
minimization. A monomer from the bovine GPx structure was minimized similarly for 
comparison. Additional details regarding these computational studies, the parameters used, as 
well as further optimization and analysis of the HCV viral GPx model using molecular 
dynamics, are reported in a separate publication [3]. 
 
RESULTS AND DISCUSSION 
 
Virus sequence database searches using variants of the Sec encoding region of GPx led to the 
identification of the GPx homology region in HCV, where the hypothetical GPx gene is in the -1 
reading frame overlapping a known nonstructural gene, NS4b, of previously unidentified 
function. The overlapping region contains one in-frame "stop" codon, UGA, that can potentially 
encode Sec; this region also lacks a start codon. This may help to explain why this putative gene 
has not been noted previously, because it does not look like an open reading flame, and a known 
gene is encoded in the same region of RNA. The Se-dependent GPx sequence and UGA codon 
are well conserved in HCV genotype 1b (which is predominant in North America), and also in 
subtypes 2b and 3a. In several other HCV subtypes (la, lc), the UGA codon has mutated to an 
AGA (arginine) codon, a mutation which may be consistent with a non-Se-dependent 
GPx activity. The same mutation was noted in the putative HIV-1 GPx gene, in subtypes 
prevalent in Africa and Asia, whereas the UGA codon (Se-GPx) was conserved in the sub)-pes 
predominant in Europe and the Americas [8]. 
 
As shown in the simplified multiple sequence alignment of Figure 1, the putative HCV GPx 
sequence has regions of substantial similarity to known GPx sequences; the similarity 
encompasses the entire sequence, but is strongest in the active site regions. For a sequence block 
of about 25 residues (beginning VNVAS...) spanning active site region l, the similarity is 
statistically significant at > 6 SD relative to random sequences of similar composition. The HCV 
GPx has features of both the plasma and cellular GPx types. 
 
 
Figure 1. Simplified multiple sequence alignment (single letter amino acid code) of the HCV 
encoded GPx homologue vs. a set of Se-GPx sequences. Two HCV genotype 1b strains are 
shown as V1 and V2; P1–P4 are plasma GPx, C1–C4 are cellular GPx. The symbol # indicates 
the positions of the conserved catalytic triad of Sec (U), Gln (Q) and Trp (W) in active regions 
R1 to R3. Letters on the line above the alignment indicate an exact match between an HCV 
residue and one or more of the mammalian GPx sequences; an asterisk indicates a chemically 
similar residue. For brevity, 2 regions of the alignment are not shown: an N-terminal region of 
35-40 residues and an internal region at %, of 25-40 residues. The symbol @ indicates an 
insertion of 11 amino acids in HCV, containing a conserved Trp residue, which, in many HCV 
isolates where this reading frame is more severely truncated at the 3′ (C-terminal) end, may serve 
to substitute for the function of the active site Trp in R3. 
 
As discussed in detail previously [11], the HCV GPx is probably expressed via 1LNA editing 
rather than the ribosomal frameshift mechanism proposed for the HIV-1 GPx gene [10]. The 
putative RNA editing site in HCV, consisting of a homopyrimidine sequence (CCUCCCUU) 
with a triplet of C bases, is just downstream of a known HCV protease cleavage site 
(FDEMEEC/ASHLP), at the NS4a-NS4b junction in the main polyprotein open reading frame. 
This implies that, when translated front an edited RNA, the HCV GPx would be cleaved from the 
viral polyprotein only a few residues upstream from the beginning of the GPx homology region. 
This processing to form an independent protein suggests a predominantly intracellular and 
possible intravirion role for the HCV GPx. 
 
A molecular model of the putative HCV GPx homologue was constructed using the HCV 
subtype lb sequence shown in Figure 1 as sequence V2 (Genbank accession #D504830. There is 
one insertion of about 10 residues in HCV (at the position shown by the symbol @ in Figure 1), 
which contains several highly conserved residues, including an Arg and a Trp, that are likely to 
play an important role in the viral GPx homologue. However, because this has no direct 
structural equivalent in the bovine GPx structure, we did not attempt to model this insertion 
explicitly. All of the other insertions and deletions proved to be structurally feasible, because of 
extensive coiling of the protein backbone in the affected regions. Minimization of the protein 
model lead to a substantially negative molecular mechanics "strain" energy of -2,002 kcal/mole 
for 133 residues (-15.1 kcal/mole·residue), which on a per-residue basis is reasonably close to, 
but not quite as low as, the value obtained by minimizing the bovine GPx crystal structure,  
-3,619 kcal/mole for 185 residues (-19.6 kcal/mole·residue). Part of the difference arises because 
the HCV GPx has less electrostatic stabilization than the bovine GPx because the former has a 
net positive charge, which might be functionally significant (e.g., suggesting association of the 
viral GPx with the negatively charged backbone of the viral RNA in the virion, or with 
phospholipid membrane of the viral envelope or infected cell). Furthermore, the geometry of the 
GPx active site, and distances between active site residues, are not substantially changed in the 
model (Figure 2). Thus, overall, the molecular modeling results suggest that the proposed 
homology is structurally feasible. 
 
 
Figure 2. A comparison of the protein backbone and active site residues of the bovine GPx 
monomer (left) and a homology molecular model of the putative HCV viral GPx enzyme (right). 
The protein backbone is shown as a ribbon, and the sidechains of the catalytic triad of Sec, Gln 
and Trp are shown using a ball and stick rendition. The Se atom of the Sec residue is indicated. 
 
Several additional lines of evidence support the hypothesis that Se status may play a role in HCV 
disease progression and outcome: 
 
1. The best direct evidence consistent with an HCV-Se link are the clinical data of Look et 
al. [4], who found that in HIV+ patients, the progressive decline in Se levels 
characteristic of HIV infection was greater in those with HCV co-infection, who "showed 
markedly lower Se concentrations compared to those without concomitant HCV-
infection" [4]. 
2. HCV infection has been associated with dilated cardiomyopathy consequent to viral 
myocarditis [9]; this is similar to Keshan disease, the classical Se-deficiency disease, 
which is characterized by cardiomyopathy. Keshan disease is believed to involve a viral 
cofactor, coxsackie virus, which shows increased cardiovirulence in Se deficient hosts 
[1]. Cardiomyopathy has also been linked to Se deficiency in HIV infection [10]. 
3. Oxidant stresses like alcoholism and iron overload are associated with HCV disease 
progression, suggesting an antioxidant impairment is involved in pathogenesis. This iron 
effect is so significant that phlebotomy or intentional bleeding has been found to 
significantly improve recovery and response to interferon treatment in HCV infection [6 
I. Unbound iron is a powerful generator of reactive oxygen species via the Fenton 
reaction. Se protects against such free radicals and peroxides, and Se sequestration in a 
viral protein could make the host more susceptible to oxidative stress. 
4. In several studies, people of low socioeconomic status were observed to have the highest 
risk of HCV infection; this is consistent with the possibility that malnutrition and 
consequent Se deficiency can enhance vulnerability to HCV infection, or increase 
chronicle of the infection by making it more difficult to overcome a primary infection. 
 
In regard to the question of what a vires might gain by encoding a GPx, there are a number of 
possibilities: 1. A vitally-encoded GPx could help a virus defend against free radical mediated 
attacks on infected cells by the immune system. 2. If associated with the viral particle, a viral 
GPx could also increase the extracellular viability of virus particles in the blood and extracellular 
compartments, at least in the case of an enveloped virus such as HCV, which is more susceptible 
to membrane lipid peroxidation once it has budded off the host cell and has lost the benefit of 
cellular antioxidant defenses. 3. A viral GPx might also have a regulatory (and potentially 
repressive) effect on viral replication, because, for example, it is known that oxidative stress (e.g. 
H2O2 exposure) activates the replication of HIV-1 and other viruses: a viral GPx would reduce 
oxidant tone, thus reducing viral activation. 4. A viral GPx might play a role in attachment to or 
penetration of target cells. 
 
Whatever the specific benefits that the virus may gain by encoding a Se-dependent GPx gene, it 
is likely that one mechanism of viral pathogenesis resulting from the expression of that gene 
would be competition between viral and host selenoprotein synthesis, particularly under 
conditions where dietary Se intake is suboptimal, as is the case in many human populations. 
Stated differently, the expression of this viral gene could lead to a decline in cellular 
selenoprotein levels, and thus make the host more susceptible to the effects of Se deficiency. !L 
as suggested above, GPx can act as a negative regulator of viral replication (which has been 
established in the case of HlV-1 [11]), then Se deficiency might also be associated with enhanced 
viral replication, and higher viral loads. In contrast, supplementation with Se should act to 
minimize the negative impact of viral GPx expression on host selenoprotein expression, while 
slowing viral replication. In essence, by this hypothesis, the effect of Se on HCV infection would 
be to tend to stablish a homeostasis between the virus and the host. Other antioxidants that are 
either Se-sparing (e.g. vitamin E) or that boost glutathione levels (e.g. lipoic acid) could act 
similarly to or synergistically with Se in HCV infection. It must be emphasized that these 
hypotheses as to potential antiviral mechanisms of Se and other antioxidants vs. HCV are purely 
speculative and have yet to be definitively tested by in-vitro or in-vivo studies. However, the 
question of mechanism aside, there do appear to be clinical benefits associated with antioxidant 
therapy of HCV infection [2]. 
 
CONCLUSIONS 
 
The prediction of GPx coding potential in HCV is primarily based upon the presence and 
conservation of significant protein sequence homology, particularly in active site regions, 
combined with evidence that the gene region in question may be expressed by known 
mechanisms of RNA editing and readthrough suppression. The specific viral mechanisms or 
RNA structure features that might be involved in recoding the UGA codon for translation as Sec 
remain to be identified. The results of the molecular modeling studies, and a number of 
independent lines of clinical evidence are also consistent with the hypothesis. 
 
The existence of an HCV encoded Se-GPx, well conserved in genotype 1b, may help to explain 
certain clinical aspects of HCV infection. Significantly, genotype 1b is associated with the 
highest risk of progression to cirrhosis and hepatocellular carcinoma, and poor response to 
interferon. The outcome of chronic HCV infection is currently difficult to predict, and many 
carriers never manifest symptoms of disease, which begs the question as to what individual or 
environmental factors determine that outcome Our results suggest that correlations between 
HCV disease progression and factors such as dietary Se intake and blood levels, markers of lipid 
peroxidation, etc., should be systematically investigated as potential correlates and predictors of 
outcome m HCV infection. 
 
In the light of our findings, it is of considerable interest that Berkson [2] has reported the 
successful treatment of individual cases of HCV-associated viral hepatitis with an antioxidant 
regimen that includes lipoic acid and Se. Thus, the potential of dietary antioxidants as primary or 
complementary therapies for HCV infection merits serious investigation. 
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